Newsroom
Sorted by: Latest
-
Promega stellt auf der SLAS 2026 eine Technologie zur Bestimmung der zellulären Zielbindung vor, die darauf abzielt, das Proteom für die Arzneimittelentwicklung zu erweitern
MADISON, Wisconsin--(BUSINESS WIRE)--Die Promega Corporation führt eine neue Plattform für die Zielbindung in lebenden Zellen ein, die eine seit langem bestehende Kluft zwischen biochemischen und zellulären Assays für wenig erforschte oder schwer zu untersuchende Proteine schließen könnte. Das TarSeer™ BRETSA™ Target Engagement System ist ein neuartiger, auf Biolumineszenz-Resonanzenergietransfer basierender Shift-Assay zum Nachweis von Liganden-Protein-Wechselwirkungen in intakten Zellen unter...
-
Promega dévoile une technologie d’engagement cellulaire ciblée visant à élargir le protéome médicamenteux lors du SLAS 2026
MADISON, Wisconsin--(BUSINESS WIRE)--Promega Corporation lance une nouvelle plateforme d’engagement ciblé sur cellules vivantes qui pourrait combler un fossé de longue date entre les tests biochimiques et cellulaires pour les protéines peu étudiées ou difficiles à interroger. Le système d’engagement des cibles TarSeer™ BRETSA™ est un nouveau test de détection basé sur le transfert d’énergie par résonance bioluminescente qui permet de détecter les interactions entre les ligands et les protéines...
-
Promega onthult technologie voor cellulair target engagement bedoeld voor uitbreiding van het met geneesmiddelen behandelbare proteoom tijdens SLAS 2026
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation lanceert een nieuw live-cell target engagement-platform dat een reeds lang bestaande leemte kan dichten tussen biochemische en cellulaire proeven voor te weinig bestudeerde of moeilijk te onderzoeken eiwitten. Het TarSeer™ BRETSA™ Target Engagement System is een nieuwe overdrachtstest gebaseerd op bioluminescentieresonantie-energieoverdracht voor het detecteren van ligand-eiwit interacties in intacte cellen door gebruik te maken van denaturati...
-
SBTS and ZIM Connections Bring Travel eSIM to Global Travelers
TOKYO--(BUSINESS WIRE)--SBTS, the joint venture between BTS and SoftBank Corp., and ZIM Connections today announced a strategic partnership to launch a travel eSIM solution, initially focused on inbound and outbound travel into and from Japan. The service is now live and commercially available here, marking the first step in a broader global rollout of multiple travel eSIM offerings. The initial launch is a digital travel eSIM platform developed by ZIM Connections and commercialized by SoftBank...
-
Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025. Inovio describes itself as a “biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”).” For more information, su...
-
Rosen Law Firm Urges Masonite International Corporation (NYSE: DOOR) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June 5, 2023 and February 8, 2024. Masonite describes itself as a “leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation...
-
Valaris Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Valaris Limited - VAL
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Valaris Limited (NYSE: VAL) to Transocean Ltd. (NYSE: RIG). Under the terms of the proposed transaction, shareholders of Valaris will receive 15.235 shares of Transocean stock for each share of Valaris that they own. KSF is seeking to determine whether this consideration and the process that led to...
-
SunOpta Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SunOpta Inc. - STKL
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of SunOpta Inc. (NasdaqGS: STKL) to Refresco. Under the terms of the proposed transaction, shareholders of SunOpta will receive $6.50 in cash for each share of SunOpta that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consi...
-
Marine Products Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marine Products Corporation - MPX
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marine Products Corporation (NYSE: MPX) to MasterCraft Boat Holdings, Inc. (NasdaqGM: MCFT). Under the terms of the proposed transaction, shareholders of Marine Products will receive $2.43 in cash and 0.232 shares of MasterCraft common stock for each share of Marine Products that they own. Upon clos...
-
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $3.8 billion aggregate principal amount (the “Offering”) of the following notes: $1.0 billion aggregate principal amount of its 4.215% senior notes due 2031 (the “2031 notes”) at the issue price of 100.000% of their principal amount; $750 million aggregate principal amount of its 4.550% senior notes due 2033 (the “2033 notes”) at the issue price of 99.78...